In Silico and in Vitro Modeling of Hepatocyte Drug Transport Processes: Importance of ABCC2 Expression Levels in the Disposition of Carboxydichlorofluroscein

K Howe; GG Gibson; T Coleman; N Plant

doi:10.1124/dmd.108.022921

Back

In Silico and in Vitro Modeling of Hepatocyte Drug Transport Processes: Importance of ABCC2 Expression Levels in the Disposition of Carboxydichlorofluroscein

Journal article

Peer reviewed

In Silico and in Vitro Modeling of Hepatocyte Drug Transport Processes: Importance of ABCC2 Expression Levels in the Disposition of Carboxydichlorofluroscein

K Howe, GG Gibson, T Coleman and N Plant

DRUG METABOLISM AND DISPOSITION, Vol.37(2), pp.391-399

01/02/2009

DOI: https://doi.org/10.1124/dmd.108.022921

Abstract

Science & Technology

Life Sciences & Biomedicine

Pharmacology & Pharmacy

PHARMACOLOGY & PHARMACY

MESSENGER-RNA EXPRESSION

RAT HEPATOCYTES

INHIBITION

CELLS

LIVER

CLASSIFICATION

SUPERFAMILY

METABOLISM

RECEPTORS

SYSTEM

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000262623000022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

1 File views/ downloads

21 Record Views

13 Times Cited - Web of Science

Details

Title: In Silico and in Vitro Modeling of Hepatocyte Drug Transport Processes: Importance of ABCC2 Expression Levels in the Disposition of Carboxydichlorofluroscein
Creators: K Howe
GG Gibson
T Coleman
N Plant
Publication Details: DRUG METABOLISM AND DISPOSITION, Vol.37(2), pp.391-399
Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
Date published: 01/02/2009
Date submitted: 15/04/2011
Identifiers: 99513522002346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

In Silico and in Vitro Modeling of Hepatocyte Drug Transport Processes: Importance of ABCC2 Expression Levels in the Disposition of Carboxydichlorofluroscein

Abstract

Files and links (1)

Metrics

Details

Usage Policy